Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.877,26
-0,30%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Enochian Biosciences Inc (ENOB) Enochian Biosciences Inc (ENOB) Notizie

ENOB

Enochian Biosciences (ENOB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ENOB
DataOraFonteTitoloSimboloCompagnia
30/04/202422:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENOBEnochian Biosciences Inc
24/04/202423:23Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
08/04/202423:44Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
19/03/202416:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
13/03/202420:45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
16/02/202415:38Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
14/02/202423:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ENOBEnochian Biosciences Inc
16/01/202423:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ENOBEnochian Biosciences Inc
03/01/202414:00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:ENOBEnochian Biosciences Inc
22/12/202323:25Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:ENOBEnochian Biosciences Inc
30/10/202314:15Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
21/10/202303:47Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ENOBEnochian Biosciences Inc
28/06/202313:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENOBEnochian Biosciences Inc
23/06/202323:00GlobeNewswire Inc.Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder MeetingNASDAQ:ENOBEnochian Biosciences Inc
08/06/202314:45GlobeNewswire Inc.Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA ReviewNASDAQ:ENOBEnochian Biosciences Inc
19/05/202323:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ENOBEnochian Biosciences Inc
19/05/202323:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ENOBEnochian Biosciences Inc
16/05/202322:35Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ENOBEnochian Biosciences Inc
12/05/202323:27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ENOBEnochian Biosciences Inc
04/04/202322:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENOBEnochian Biosciences Inc
03/04/202315:00GlobeNewswire Inc.Enochian BioSciences’ CEO Letter to ShareholdersNASDAQ:ENOBEnochian Biosciences Inc
29/03/202315:00GlobeNewswire Inc.Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading ResearcherNASDAQ:ENOBEnochian Biosciences Inc
13/03/202313:30GlobeNewswire Inc.Enochian BioSciences Achieves Full Compliance with NASDAQ Filing RequirementsNASDAQ:ENOBEnochian Biosciences Inc
23/02/202322:04GlobeNewswire Inc.Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022NASDAQ:ENOBEnochian Biosciences Inc
30/11/202223:20GlobeNewswire Inc.Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022NASDAQ:ENOBEnochian Biosciences Inc
15/11/202223:24Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ENOBEnochian Biosciences Inc
24/10/202214:00GlobeNewswire Inc.Enochian BioSciences Forges Ahead With Focused Approach, Promising FutureNASDAQ:ENOBEnochian Biosciences Inc
21/10/202223:00TipRanksEnochian Biosciences receives Nasdaq notice regarding delayed filingNASDAQ:ENOBEnochian Biosciences Inc
21/10/202223:00GlobeNewswire Inc.Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-KNASDAQ:ENOBEnochian Biosciences Inc
17/10/202214:30GlobeNewswire Inc.Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology PlatformNASDAQ:ENOBEnochian Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ENOB

La tua Cronologia

LSE
WRCY
Wte Wrcy Acc
COIN
YOVIEUR
UNSW3
THOLETH
Tholos
COIN
BEPUSD
BLUCON
LSE
0DJN
Alma Media Oyj
NASDAQ
DEACW
Diamond Eagle Acquisition
USOTC
UEPEM
Union Electric (PK)
XE
ECF
Mountain Alliance
BMF
DIIF26N26
DIIF26N26 - 01/2026
KUCN
USDDUSDT
Decentralized USD
EU
F627S
F627S
EU
5422T
5422T
HITB
BTBBTC
Bitball
MRTX
ECOETH
EcoCrypto
BIT
F16333
Vontobel Financial Produ...
BIT
F18978
Vontobel Financial Produ...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network